Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20090102/LAF001LOGO)
"MedClean Technologies is the result of our efforts to create a break-outbusiness model that makes it easy for healthcare institutions to embrace theCompany's onsite solutions for RMW treatment and management, which helphospitals reduce expenses, mitigate risks, and protect the environment," saidScott Grisanti, President and Chief Executive Officer of MedClean.
Advertisement
MedClean Technologies leverages the Company's established technology withrecent and future advancements and a new, customer-focused business model todeliver sophisticated, comprehensive and fully integrated on-demand solutionsfor the treatment and volume reduction of RMW and HIPAA-compliant destructionof confidential documents. These solutions are delivered in industry-standardcontainers that require no installation within an institution's facility,reducing the required footprint within a facility. The proprietary MedCleanContainer Series configuration, which is the subject of a patent filing,includes features that facilitate easy access to hospital utilities, inaddition to options for on-board utilities in the event that electric and/orsteam are not easily accessible. The MedClean Mobile Series addstransportability, allowing multi-site healthcare organizations to costeffectively leverage a system across several locations.
"To make MedClean's on-demand solutions accessible to more healthcareinstitutions, we have added a variety of acquisition options," said Mr.Grisanti. "In addition to traditional capital purchases, we have added leaseand rental programs to match the demands of target customers and significantlyexpand the Company's overall market opportunity. A MedClean Container systemcan replace one or more trailers from off-site providers for RMW andconfidential documents. In a similar manner, the expense for a MedCleanContainer rental can replace -- at a lower cost -- the expense for one or moreoff-site vendors."
Recent Developments
As part of the re-launch of the Company as MedClean Technologies, andparticularly since the recapitalization in early August, the Company hascompleted several important initiatives and strengthened its competitiveposition. Initiatives include an augmented board of directors and new,professional management, as well as an application for a new patent tostrengthen the Company's intellectual property position. Recent additions tothe leadership team include:
-- The strengthening of the board of directors with the addition of JosephEsposito (director and Chairman of the Board) and Kenneth Londoner (director).
-- The appointment of Scott Grisanti as President and CEO and a directorof the Company.
-- The appointment of John R. Accardi as Senior VP of Sales and David J.Laky as Senior VP of Client Services, responsible for professional services,customer care, engineering and manufacturing.
"During the last six months, we have taken the necessary steps to developa customer-focused business plan and deploy professional management and anexperienced, shareholder-focused board of directors," Mr. Grisanti added."Today, MedClean emerges a stronger organization with a proven leadership teamin place poised to accelerate the execution of a differentiated business planthat capitalizes on a sustainable competitive advantage. I anticipate thatour efforts over the past six months will produce visible results for ourshareholders during 2009."
In addition to the MedClean Container configuration, the patent filing:"Containerized Medical Waste Treatment System and Related Method," also coversthe treatment protocol used to achieve a superior level of RMW sterilization.A single MedClean Container system can treat 1 million pounds of RMW per year,in addition to handling confidential document destruction. The appropriateprocessing and destruction of confidential medical documents is an importantconsideration under federal HIPAA regulations.
"The intellectual property articulated in our patent filing provides asustainable competitive advantage to MedClean Technologies and our customers,"added Mr. Grisanti. "Combined with our system workflow, which minimizeshandling of bio-hazardous waste by healthcare workers, MedClean systemsmitigate risk by addressing 'cradle-to-grave' hospital responsibility foruntreated RMW. Once treated, the volume of sterilized waste is reduced by 80to 85%, which minimizes the carbon footprint of healthcare organizations,while onsite sterilization also eliminates the need to transport untreated RMWthrough host communities, an issue which currently represents a liability forhospitals.
"In short, the advanced MedClean system will lower expenses, reduce theenvironmental impact, and eliminate unnecessary risks for hospitals,"concluded Mr. Grisanti. "These messages, along with our attractive pricingoptions, will resonate with cost and image-conscious healthcare organizations.We also believe the new model will enable us to target a far wider range ofhealthcare organizations, benefiting our shareholders and enabling us to scalerevenue more rapidly compared to prior business models."
About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology andservices for the onsite treatment and disposal of regulated medical waste.MedClean's flagship MedClean(R) Series systems are fully integrated, turnkeytechnology solutions that enable hospitals and other healthcare providers tosafely, efficiently and cost-effectively convert bio-hazardous regulatedmedical waste into sterile, unrecognizable material suitable for disposal asmunicipal solid waste. MedClean was founded in 1997 with corporateheadquarters, research and development and distribution facilities located inBethel, Connecticut. Further information on MedClean can be found athttp://www.medcleantechnologies.com and in filings with the Securities andExchange Commission found at http://www.sec.gov.
Statements about our future expectations are "forward-looking statements"within the meaning of applicable Federal Securities Laws, and are notguarantees of future performance. When used herein, the words "may," "will,""should," "anticipate," "believe," "appear," "intend," "plan," "expect,""estimate," "approximate," and similar expressions are intended to identifysuch forward-looking statements. These statements involve risks anduncertainties inherent in our business, including those set forth in our mostrecent Annual Report on Form 10-K for the year ended December 31, 2007, filedwith the SEC on March 31, 2008, and other filings with the SEC, and aresubject to change at any time. Our actual results could differ materially fromthese forward-looking statements. We undertake no obligation to updatepublicly any forward-looking statement.Contacts: MedClean Technologies, Inc. Investor Contact: Kevin Dunphy Cameron Donahue Chief Financial Officer Hayden IR (203) 798-1080 (651) 653-1854 [email protected] [email protected]
SOURCE MedClean Technologies, Inc.
